ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 127 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $848,756 | +563.1% | 36,010 | +1099.9% | 0.00% | – |
| Q1 2021 | $128,000 | -64.9% | 3,001 | -54.5% | 0.00% | – |
| Q4 2020 | $365,000 | +393.2% | 6,602 | +126.8% | 0.00% | – |
| Q3 2020 | $74,000 | -22.9% | 2,911 | -28.3% | 0.00% | – |
| Q2 2020 | $96,000 | +9500.0% | 4,059 | +7558.5% | 0.00% | – |
| Q1 2020 | $1,000 | -98.8% | 53 | -98.6% | 0.00% | – |
| Q4 2019 | $86,000 | +186.7% | 3,777 | +44.8% | 0.00% | – |
| Q3 2019 | $30,000 | -21.1% | 2,608 | +4.1% | 0.00% | – |
| Q2 2019 | $38,000 | +850.0% | 2,506 | +755.3% | 0.00% | – |
| Q4 2018 | $4,000 | 0.0% | 293 | +103.5% | 0.00% | – |
| Q3 2018 | $4,000 | -97.1% | 144 | -98.0% | 0.00% | – |
| Q2 2018 | $139,000 | +6.9% | 7,116 | +2.1% | 0.00% | – |
| Q1 2018 | $130,000 | – | 6,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |